{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:24:57Z","timestamp":1792297497456,"version":"4.4.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Oulu University Hospital"},{"DOI":"10.13039\/100008723","name":"Finnish Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Finnish Research Foundation of Gynecology and Obstetrics, UniOGS Graduate School"},{"DOI":"10.13039\/501100008403","name":"Finnish Medical Society Duodecim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008403","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>STUDY QUESTION<\/jats:title>\n                    <jats:p>Is there an association between premature ovarian insufficiency (POI) and severe autoimmune diseases before and after POI diagnosis?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY ANSWER<\/jats:title>\n                    <jats:p>Women with POI had at least one hospital-treated autoimmune disorder preceding POI diagnosis 2.6 times more often compared with matched female controls, and a 2- to 3-fold risk for these diseases for several years after POI diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                    <jats:p>It has been suggested that autoimmunity is an important factor in the pathogenesis of POI. Estimations of the prevalence of POI cases with autoimmune origin have ranged from 4% to 50%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                    <jats:p>This population-based registry study included 3972 women diagnosed with spontaneous POI between 1988 and 2017 and 15\u00a0708 female population controls and used both case\u2013control and cohort analysis. Autoimmune disease diagnoses were evaluated from childhood until the end of the year 2017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                    <jats:p>Women with POI were identified from the reimbursement registry of the Finnish Social Insurance Institution by their right to hormone replacement therapy (HRT). Four female population controls matched by age and municipality of residence were searched for each POI case to form a reference cohort. Women with a history of cancer or bilateral oophorectomy were excluded. Severe autoimmune disorder diagnoses for the years 1970\u20132017 were identified from the Hospital Discharge Registry. Odds ratios (ORs) with 95% confidence intervals (CI) were calculated using binary logistic regression for cases of having any, or one or more, specific autoimmune diseases preceding the index date (the date when reimbursement for HRT was granted for the POI) among women with POI as compared to controls. Standardized incidence ratios (SIR) with 95% CIs for getting diagnosed with an autoimmune disease after the index date in 3-year follow-up periods among women with POI (who did not have these diseases prior to the index date) were also calculated. The expected numbers of autoimmune disease cases were based on the incidence of first-onset severe autoimmune disease among the controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                    <jats:p>The prevalence of having at least one severe autoimmune disease in women with POI was 5.6% (n\u2009=\u2009233), with an OR of 2.6 (95% CI 2.2, 3.1) when compared to population controls. Women with POI had an increased prevalence of several specific autoimmune diseases prior to the index date compared to controls: polyglandular autoimmune diseases (OR 25.8, 95% CI 9.0, 74.1), Addison\u2019s disease (OR 22.9, 95% CI 7.9, 66.1), vasculitis (OR 10.2, 95% 4.3, 24.5), systemic lupus erythematosus (OR 6.3 95% CI 4.2, 20.3), rheumatoid arthritis (OR 2.3, 95% CI 1.7, 3.2), sarcoidosis (OR 2.3, 95% CI 1.2, 4.5), inflammatory bowel diseases (OR 2.2, 95% CI 1.5, 3.3), and hyperthyroidism (OR 1.9, 95% CI 1.2, 3.1); whereas the prevalence of diabetes type 1 and ankylosing spondylitis did not differ between the women with POI and the reference cohort. The SIRs for being diagnosed for the first time with a severe autoimmune disease after POI diagnosis was 2.8 (95% CI 2.3, 3.4), during the first three years after POI diagnosis, decreasing gradually to 1.3 (1.1, 1.6) after 12\u2009years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                    <jats:p>This study only included autoimmune disorders diagnosed in specialized health care; hence, the overall prevalence of autoimmune disorders in women with POI may be higher.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                    <jats:p>Severe autoimmune diseases have a strong association with POI, suggesting that immunological mechanisms play a pivotal role in POI. Future studies should focus on specific autoimmune mechanisms behind POI, from both preventive and curative perspectives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                    <jats:p>This work was financially supported by Oulu University Hospital. S.M.S. received grants from the Finnish Menopause Society, the Finnish Medical Foundation, and the Juho Vainio Foundation. H.S. received grants from the Finnish Menopause Society, the Oulu Medical Research Foundation, the Finnish Research Foundation of Gynecology and Obstetrics, UniOGS graduate school, The Finnish Medical Society Duodecim, Orion Research Foundation, and the University of Oulu Scholarship Fund. M.-M.O. received a grant from the Sakari Alhopuro Foundation and the Finnish Diabetes Research Foundation. None of the funders had any involvement in the study design or its execution or reporting. The authors do not have any competing interests to report.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                    <jats:p>N\/A.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humrep\/deae213","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T13:32:52Z","timestamp":1725629572000},"page":"2601-2607","source":"Crossref","is-referenced-by-count":36,"title":["Excess of severe autoimmune diseases in women with premature ovarian insufficiency: a population-based study"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2491-0458","authenticated-orcid":false,"given":"S M","family":"Savukoski","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia , Pohde, Oulu,","place":["Finland"]},{"name":"Research Unit of Clinical Medicine, University of Oulu , Oulu,","place":["Finland"]},{"name":"Medical Research Center, University of Oulu and Oulu University Hospital, Wellbeing Services County of North Ostrobothnia , Oulu,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6820-5705","authenticated-orcid":false,"given":"H","family":"Silv\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia , Pohde, Oulu,","place":["Finland"]},{"name":"Research Unit of Clinical Medicine, University of Oulu , Oulu,","place":["Finland"]},{"name":"Medical Research Center, University of Oulu and Oulu University Hospital, Wellbeing Services County of North Ostrobothnia , Oulu,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4215-3430","authenticated-orcid":false,"given":"P","family":"Pesonen","sequence":"additional","affiliation":[{"name":"Infrastructure for Population Studies, Faculty of Medicine, University of Oulu , Oulu,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Pukkala","sequence":"additional","affiliation":[{"name":"Health Sciences Unit, Faculty of Social Sciences, Tampere University , Tampere,","place":["Finland"]},{"name":"Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research , Helsinki,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8254-7525","authenticated-orcid":false,"given":"M","family":"Gissler","sequence":"additional","affiliation":[{"name":"Information Department, THL Finnish Institute for Health and Welfare , Helsinki,","place":["Finland"]},{"name":"Academic Primary Health Care Centre, Region Stockholm , Stockholm,","place":["Sweden"]},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Suvanto","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia , Pohde, Oulu,","place":["Finland"]},{"name":"Research Unit of Clinical Medicine, University of Oulu , Oulu,","place":["Finland"]},{"name":"Medical Research Center, University of Oulu and Oulu University Hospital, Wellbeing Services County of North Ostrobothnia , Oulu,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6794-0369","authenticated-orcid":false,"given":"M -M","family":"Ollila","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia , Pohde, Oulu,","place":["Finland"]},{"name":"Research Unit of Clinical Medicine, University of Oulu , Oulu,","place":["Finland"]},{"name":"Medical Research Center, University of Oulu and Oulu University Hospital, Wellbeing Services County of North Ostrobothnia , Oulu,","place":["Finland"]},{"name":"Department of Internal Medicine, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia , Pohde, Oulu,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0927-0472","authenticated-orcid":false,"given":"M","family":"Niinim\u00e4ki","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia , Pohde, Oulu,","place":["Finland"]},{"name":"Research Unit of Clinical Medicine, University of Oulu , Oulu,","place":["Finland"]},{"name":"Medical Research Center, University of Oulu and Oulu University Hospital, Wellbeing Services County of North Ostrobothnia , Oulu,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"key":"2024110408195739600_deae213-B1","first-page":"QC10","article-title":"Premature ovarian failure: an association with autoimmune diseases","volume":"10","author":"Jha","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"2024110408195739600_deae213-B2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/EJE-09-0231","article-title":"Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure","volume":"161","author":"Bachelot","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2024110408195739600_deae213-B3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaut.2012.01.015","article-title":"Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency","volume":"38","author":"Bakalov","year":"2012","journal-title":"J Autoimmun"},{"key":"2024110408195739600_deae213-B4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/13697137.2023.2287631","article-title":"Premature ovarian insufficiency and autoimmune profiles: a prospective case-control study","volume":"27","author":"Beitl","year":"2024","journal-title":"Climacteric"},{"key":"2024110408195739600_deae213-B5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.clim.2013.02.010","article-title":"Autoimmune diseases and reproductive aging","volume":"149","author":"Bove","year":"2013","journal-title":"Clin Immunol"},{"key":"2024110408195739600_deae213-B6","doi-asserted-by":"crossref","first-page":"e32500","DOI":"10.1097\/MD.0000000000032500","article-title":"A review of autoimmunity and immune profiles in patients with primary ovarian insufficiency","volume":"101","author":"Chen","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"2024110408195739600_deae213-B7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1568-9972(03)00006-5","article-title":"The epidemiology of autoimmune diseases","volume":"2","author":"Cooper","year":"2003","journal-title":"Autoimmun Rev"},{"key":"2024110408195739600_deae213-B8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/13625187.2019.1702638","article-title":"Prevalence of autoimmune disease in women with premature ovarian failure","volume":"25","author":"Grossmann","year":"2020","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"2024110408195739600_deae213-B9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/ije\/dyu045","article-title":"Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort","volume":"43","author":"Harps\u00f8e","year":"2014","journal-title":"Int J Epidemiol"},{"key":"2024110408195739600_deae213-B10","doi-asserted-by":"crossref","first-page":"e12427","DOI":"10.1002\/rmb2.12427","article-title":"Effect of hypothyroidism and thyroid autoimmunity on the ovarian reserve: a systematic review and meta-analysis","volume":"21","author":"Hasegawa","year":"2022","journal-title":"Reprod Med Biol"},{"key":"2024110408195739600_deae213-B11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/17538157.2017.1297306","article-title":"How reliable are health registers? Registration of induced abortions and sterilizations in Finland","volume":"43","author":"Heino","year":"2018","journal-title":"Inform Health Soc Care"},{"key":"2024110408195739600_deae213-B12","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/aogs.14445","article-title":"National register data are of value in studies on miscarriage \u2013 validation of the healthcare register data in Finland","volume":"101","author":"Helle","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2024110408195739600_deae213-B13","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/humrep\/deab025","article-title":"Thyroid autoimmunity is associated with higher risk of premature ovarian insufficiency-a nationwide Health Insurance Research Database study","volume":"36","author":"Hsieh","year":"2021","journal-title":"Hum Reprod"},{"key":"2024110408195739600_deae213-B14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(68)91053-2","article-title":"Immunological aspects of premature ovarian failure associated with idiopathic Addison\u2019s disease","volume":"2","author":"Irvine","year":"1968","journal-title":"Lancet"},{"key":"2024110408195739600_deae213-B15","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1210\/jc.2016-3960","article-title":"Premature ovarian insufficiency: phenotypic characterization within different etiologies","volume":"102","author":"Jiao","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2024110408195739600_deae213-B16","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.3389\/fimmu.2019.03094","article-title":"Environmental exposures and autoimmune diseases: contribution of gut microbiome","volume":"10","author":"Khan","year":"2019","journal-title":"Front Immunol"},{"key":"2024110408195739600_deae213-B17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0029-7844(97)00077-X","article-title":"Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure","volume":"89","author":"Kim","year":"1997","journal-title":"Obstet Gynecol"},{"key":"2024110408195739600_deae213-B18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.21037\/apm.2020.02.11","article-title":"Assessment of ovarian reserve by serum anti-M\u00fcllerian hormone in patients with systemic lupus erythematosus: a meta-analysis","volume":"9","author":"Luo","year":"2020","journal-title":"Ann Palliat Med"},{"key":"2024110408195739600_deae213-B19","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.fertnstert.2011.07.022","article-title":"Early menopause in women with chronic inflammatory disease: a population-based cohort study","volume":"96","author":"McLaren","year":"2011","journal-title":"Fertil Steril"},{"key":"2024110408195739600_deae213-B20","doi-asserted-by":"crossref","first-page":"102266","DOI":"10.1016\/j.coi.2022.102266","article-title":"The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention","volume":"80","author":"Miller","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"2024110408195739600_deae213-B21","doi-asserted-by":"crossref","first-page":"e32487","DOI":"10.1371\/journal.pone.0032487","article-title":"Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity","volume":"7","author":"Sardu","year":"2012","journal-title":"PLoS One"},{"key":"2024110408195739600_deae213-B22","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3390\/antiox12081601","article-title":"The role of lifestyle and dietary factors in the development of premature ovarian insufficiency","volume":"8","author":"Shelling","year":"2023","journal-title":"Antioxidants(Basel)"},{"key":"2024110408195739600_deae213-B23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.autrev.2014.01.003","article-title":"Autoimmune primary ovarian insufficiency","volume":"13","author":"Silva","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2024110408195739600_deae213-B24","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/humrep\/dead066","article-title":"Association of genetic disorders and congenital malformations with premature ovarian insufficiency: a nationwide register-based study","volume":"38","author":"Silv\u00e9n","year":"2023","journal-title":"Hum Reprod"},{"key":"2024110408195739600_deae213-B25","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.4158\/EP161215.OR","article-title":"Deterioraron of ovarian function after total abdominal hysterectomy with preservaron of ovaries","volume":"22","author":"Singha","year":"2016","journal-title":"Endocr Pract"},{"key":"2024110408195739600_deae213-B26","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.fertnstert.2016.09.046","article-title":"Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause","volume":"106","author":"Sullivan","year":"2016","journal-title":"Fertil Steril"},{"key":"2024110408195739600_deae213-B27","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.3390\/ijms22052594","article-title":"Autoimmune diseases in patients with premature ovarian insufficiency\u2014our current state of knowledge","volume":"22","author":"Szeliga","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2024110408195739600_deae213-B28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2016.05.023","article-title":"Autoimmune polyglandular syndrome type 3 (APS-3) among patients with premature ovarian insufficiency (POI)","volume":"203","author":"Szlendak-Sauer","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2024110408195739600_deae213-B29","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/humrep\/dew027","article-title":"ESHRE Guideline: management of women with premature ovarian insufficiency","volume":"31","author":"Webber","year":"2016","journal-title":"Hum Reprod"},{"key":"2024110408195739600_deae213-B30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00404-020-05824-8","article-title":"Ovarian reserve in patients with ankylosing spondylitis","volume":"303","author":"Yal\u00e7\u0131n Bahat","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"2024110408195739600_deae213-B31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12020-022-03091-y","article-title":"Assessment of ovarian reserve in patients with type 1 diabetes: a systematic review and meta-analysis","volume":"77","author":"Yang","year":"2022","journal-title":"Endocrine"},{"key":"2024110408195739600_deae213-B32","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1159\/000520133","article-title":"Assessment of the ovarian reserve by serum anti-M\u00fcllerian hormone in rheumatoid arthritis patients: a systematic review and meta-analysis","volume":"183","author":"Zhang","year":"2022","journal-title":"Int Arch Allergy Immunol"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/39\/11\/2601\/60241834\/deae213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/39\/11\/2601\/60241834\/deae213.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T03:21:03Z","timestamp":1730690463000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/39\/11\/2601\/7774591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":32,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,9,25]]},"published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deae213","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,9,25]]}}}